News
PRPH
0.198
+1.49%
0.003
ProPhase Labs Updates Shareholders Amid Volatility and OTC Move
TipRanks · 1d ago
ProPhase Labs Announces Immediate Resignation of Board Member
TipRanks · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 3d ago
ProPhase Labs Says Stock Volatility Tied to Debt Conversions, Not Business Fundamentals
Benzinga · 5d ago
ProPhase Labs Reassures Investors Amid Market Volatility
Reuters · 5d ago
PROPHASE LABS PROVIDES UPDATE ON CONVERTIBLE DEBT CONVERSIONS, CAPITAL STRUCTURE, AND UNDERLYING ASSET VALUE
Reuters · 5d ago
Weekly Report: what happened at PRPH last week (1229-0102)?
Weekly Report · 5d ago
ProPhase Labs faces Nasdaq delisting, plans appeal, OTC move
TipRanks · 01/02 22:54
Nasdaq Suspends Trading of ProPhase Labs Inc. Shares
Reuters · 01/02 22:11
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 01/02 21:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 01/02 12:05
Weekly Report: what happened at PRPH last week (1222-1226)?
Weekly Report · 12/29/2025 09:26
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 12/26/2025 17:05
Weekly Report: what happened at PRPH last week (1215-1219)?
Weekly Report · 12/22/2025 09:26
Upcoming Stock Splits This Week (December 22 to December 26) – Stay Invested
TipRanks · 12/21/2025 15:20
ProPhase Labs trading halted, news pending
TipRanks · 12/20/2025 00:50
ProPhase Labs Announces Proposed Reverse Merger with ABL
TipRanks · 12/19/2025 20:57
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 12/19/2025 17:05
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
TipRanks · 12/19/2025 16:36
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results
Benzinga · 12/19/2025 15:09
More
Webull provides a variety of real-time PRPH stock news. You can receive the latest news about Prophase Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About PRPH
ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.